Tag: clinical oncology next generation sequencing market overview

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market from 2024 to 2033?

The clinical oncology next-generation sequencing market is forecast to grow from $0.45 billion in 2023 to $0.52 billion in 2024, at a CAGR of 15.5%. The market’s expansion is attributed to advances in genomic research, cancer biomarker discovery, technological innovations, and regulatory approvals.

The clinical oncology next-generation sequencing market is expected to see rapid growth, reaching $0.86 billion by 2028, with a CAGR of 13.2%. Growth is driven by increasing cancer incidence, precision medicine, immuno-oncology, and liquid biopsies. Trends include comprehensive genomic profiling (CGP), immuno-oncology, tumor evolution, and AI integration.

Claim Your Free Sample of the Global Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp

What Key Factors Are Fueling the Growth of the Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market?

The global increase in cancer cases is likely to contribute to the growth of the clinical oncology next-generation sequencing market during the forecast period. The American Cancer Society reported 1.9 million new cancer cases and 0.6 million cancer-related deaths in the USA in 2021. Lung, prostate, bowel, and breast cancer are the four most common cancers worldwide, responsible for 43% of all new cases. As the cancer incidence continues to rise globally, the demand for clinical oncology next-generation sequencing is expected to grow.

What Are the Major Segments of the Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market?

1) By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing

2) By Application: Screening, Companion Diagnostics, Other Diagnostics

3) By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic laboratories

What New Trends Are Transforming the Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market?

Companies in the clinical oncology next-generation sequencing market are investing in workflow automation to enhance precision and reduce sample variability. For example, Agilent automation solutions have developed systems to process more samples in less time while reducing variability across samples.

Order Now for Fast Delivery of Your Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market Report!

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Which Regions Are Driving Growth in the Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market?

North America was the largest region in the clinical oncology next-generation sequencing market in 2023. Asia-Pacific was the second largest region in the clinical oncology next-generation sequencing market. The regions covered in the clinical oncology next generation sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Clinical Oncology Next Generation Sequencing Global Market Report 2024 Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the clinical oncology next generation sequencing global market report 2024 market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market Include

1. Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market Executive Summary

2. Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market Segments

3. Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market Size And Template Market Growth Rate

4. Key Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market Trends

5. Major Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market Drivers

……

25. Key Mergers And Acquisitions In The Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market

26. Top Clinical Oncology Next Generation Sequencing Global Market Report 2024 Companies

27. Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market Opportunities And Strategies

28. Clinical Oncology Next Generation Sequencing Global Market Report 2024 Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Synthetic Biology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Desiccants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/desiccants-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The clinical oncology next-generation sequencing market has experienced rapid expansion in recent years, with a substantial increase from $0.45 billion in 2023 to $0.52 billion in 2024, marking an impressive Compound Annual Growth Rate (CAGR) of 15.5%. This growth in the historic period is attributed to advancements in genomic research, cancer biomarker discovery, technological progress, and regulatory approvals.

Future Projections

Anticipated to sustain its momentum, the market is poised for continued growth. Forecasts indicate an expansion to $0.86 billion in 2028, with a CAGR of 13.2%. The projected surge in the clinical oncology next-generation sequencing market in the forecast period can be linked to factors like the growing incidence of cancer, precision medicine, advancements in immuno-oncology, and the rise of liquid biopsies.

Cancer Prevalence as a Catalyst for Growth

Rising Cancer Cases

The escalating prevalence of cancer emerges as a driving force behind the growth of the clinical oncology next-generation sequencing market. Defined by the uncontrolled growth and spread of abnormal cells, cancer necessitates advanced technologies like Next-Generation Sequencing (NGS) to identify new and rare mutations. In 2021, the American Cancer Society estimated 1.9 million new cancer cases and 608,570 deaths in the United States alone, underscoring the urgency for robust diagnostic tools.

Role of NGS

NGS plays a pivotal role in understanding the molecular underpinnings of individual tumors, enabling a more targeted and personalized approach to cancer treatment. As the prevalence of cancer continues to rise globally, the demand for clinical oncology next-generation sequencing solutions is expected to surge.

View More On The Clinical Oncology Next Generation Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Innovative Products Driving Profitability

Strategic Innovations

Major players in the market, including Thermo Fisher Scientific, Illumina, and Roche, are actively innovating to introduce cutting-edge products. For example, Roche’s BenchMark ULTRA PLUS system is a testament to the industry’s commitment to innovation. Launched in June 2022, this system enhances the accuracy and efficiency of diagnostic tests, contributing to improved patient care.

Product Impact on Profitability

Innovative products not only contribute to scientific advancements but also play a significant role in boosting profitability. The BenchMark ULTRA PLUS System, by streamlining diagnostic tests and delivering rapid and accurate results, exemplifies the synergy between technological innovation and market profitability.

Strategic Acquisitions for Market Expansion

Agilent’s Strategic Move

Agilent Technologies, a key player in life sciences technology, made a strategic move in April 2021 by acquiring Resolution Bioscience. This undisclosed acquisition aimed to bolster Agilent’s capabilities in next-generation sequencing for cancer diagnostics. Resolution Bioscience, known for its precision oncology solutions, positions Agilent at the forefront of NGS-based cancer diagnostics.

Market Segmentation and Regional Dominance

Segmentation Overview

The clinical oncology next-generation sequencing market is segmented based on technology, application, and end-user. Key segments include Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing, with applications spanning Screening, Companion Diagnostics, and Other Diagnostics. End-users range from Hospital Laboratories and Clinical Research Organizations to Diagnostic Laboratories.

Regional Dominance

North America emerged as the largest region in the clinical oncology next-generation sequencing market in 2023. This regional dominance reflects the concentrated efforts and investments in advanced healthcare technologies and research initiatives.

Conclusion

In conclusion, the clinical oncology next-generation sequencing market’s dynamic growth trajectory underscores its pivotal role in advancing cancer diagnostics and treatment. With rising cancer incidence, strategic innovations, and regional dominance in North America, the market is poised for further expansion. As technological breakthroughs continue to shape the landscape, the integration of NGS in precision medicine and immuno-oncology holds the promise of transforming cancer care on a global scale.

Request A Sample Of The Global Clinical Oncology Next Generation Sequencing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3344&type=smp